Home > Financial Ratios > INDOCO REMEDIES

INDOCO REMEDIES
EV/Core EBITDA

    Back to All Ratios
INDOCO REMEDIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 14.3411.4511.2112.7717.14

What is the latest EV/Core EBITDA ratio of INDOCO REMEDIES ?

The latest EV/Core EBITDA ratio of INDOCO REMEDIES is 14.34 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202414.34
Mar202311.45
Mar202211.21
Mar202112.77
Mar202017.14

How is EV/Core EBITDA of INDOCO REMEDIES Trending?

Years EV/Core EBITDA % Change
Mar2024 14.34
25.24
Mar2023 11.45
2.14
Mar2022 11.21
-12.22
Mar2021 12.77
-25.50
Mar2020 17.14 -

Other Financial Ratios of INDOCO REMEDIES


Compare EV/Core EBITDA ratio of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹2,999.7 Cr -3.8% -3.3% -14% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹424,382.0 Cr -5.8% -3.2% 35.1% Stock Analytics
DIVIS LABORATORIES ₹159,224.0 Cr -2.8% -3.6% 44.7% Stock Analytics
CIPLA ₹116,943.0 Cr -3.9% -0.5% 13.9% Stock Analytics
DR REDDYS LABORATORIES ₹111,588.0 Cr -1.2% 7.1% 17.8% Stock Analytics
ZYDUS LIFESCIENCES ₹100,704.0 Cr -2.7% -0.1% 40.9% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

-3.8%

-3.3%

-14%

SENSEX

-2.2%

-5.9%

7.2%


You may also like the below Video Courses